A comparative study on the payment reform for therapeutic value of dominant diseases of Traditional Chinese Medicine at provincial level
10.3969/j.issn.1674-2982.2025.08.008
- VernacularTitle:省域层面中医优势病种疗效价值付费改革方案比较研究
- Author:
Qing-yan WU
1
;
Li-sha LIU
;
Min-xi GONG
;
Li-xiang ZHAI
Author Information
1. 广东药科大学医药商学院 广东 广州 510006;广东省卫生经济与健康促进研究中心 广东 广州 510006
- Publication Type:Journal Article
- Keywords:
Therapeutic value;
Dominant diseases of Traditional Chinese Medicine;
Payment
- From:
Chinese Journal of Health Policy
2025;18(8):63-70
- CountryChina
- Language:Chinese
-
Abstract:
Objective:Through the comparative analysis of the payment program for the therapeutic value of Traditional Chinese Medicine dominant diseases in 8 provinces,we found the shortcomings of the existing program and put forward the perfect policy suggestions.Methods:Comparative analysis of the core content of the programs in various places,the selection of disease types,efficacy evaluation indexes,the application of the payment link and the protection mechanism.Results:The fragmentation of existing programs is an obvious problem,the specific content settings of each item are quite different,reflecting differences in the understanding of the core content of the program,the existence of inconsistent understanding of Chinese medicine's therapeutic value,the failure to link the payment standard to the results of the therapeutic value evaluation,and the lack of recognition of the value of Chinese medicine's technical labor,among other problems.Conclusions:We can select disease types based on the prominent advantages of Traditional Chinese medicine,learn from the evaluation framework of western medicine value-based medical care,construct the evaluation system of Chinese medicine therapeutic value,and carry out"equal price"payment based on the"same effect"of health results,set performance indicators and payment standards in stages,realize the whole process management of disease,and enhance the Traditional Chinese Medicine's therapeutic value,and promote the development of Traditional Chinese Medicine inheritance and innovation.
